Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

263 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relation of risk factors with response to carvedilol in heart failure with preserved ejection fraction - a report from the Japanese Diastolic Heart Failure Study (J-DHF).
Yamamoto K, Origasa H, Suzuki Y, Takahashi T, Shinozaki T, Watanabe T, Sakata Y, Izumi C, Taira K, Hori M; J-DHF Investigators. Yamamoto K, et al. Among authors: origasa h. J Cardiol. 2014 Jun;63(6):424-31. doi: 10.1016/j.jjcc.2013.10.014. Epub 2013 Nov 25. J Cardiol. 2014. PMID: 24286855 Free article.
Effect of trapidil on cardiovascular events in patients with coronary artery disease (results from the Japan Multicenter Investigation for Cardiovascular Diseases-Mochida [JMIC-M]).
Hirayama A, Kodama K, Yui Y, Nonogi H, Sumiyoshi T, Origasa H, Hosoda S, Kawai C; Japan Multicenter Investigation for Cardiovascular Diseases-Mochida Investigators. Hirayama A, et al. Among authors: origasa h. Am J Cardiol. 2003 Oct 1;92(7):789-93. doi: 10.1016/s0002-9149(03)00884-1. Am J Cardiol. 2003. PMID: 14516877 Clinical Trial.
Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
Hori M, Sasayama S, Kitabatake A, Toyo-oka T, Handa S, Yokoyama M, Matsuzaki M, Takeshita A, Origasa H, Matsui K, Hosoda S; MUCHA Investigators. Hori M, et al. Among authors: origasa h. Am Heart J. 2004 Feb;147(2):324-30. doi: 10.1016/j.ahj.2003.07.023. Am Heart J. 2004. PMID: 14760332 Clinical Trial.
Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial.
Sato H, Ishikawa K, Kitabatake A, Ogawa S, Maruyama Y, Yokota Y, Fukuyama T, Doi Y, Mochizuki S, Izumi T, Takekoshi N, Yoshida K, Hiramori K, Origasa H, Uchiyama S, Matsumoto M, Yamaguchi T, Hori M; Japan Atrial Fibrillation Stroke Trial Group. Sato H, et al. Among authors: origasa h. Stroke. 2006 Feb;37(2):447-51. doi: 10.1161/01.STR.0000198839.61112.ee. Epub 2005 Dec 29. Stroke. 2006. PMID: 16385088 Clinical Trial.
Prevalence of atrial fibrillation in the general population of Japan: an analysis based on periodic health examination.
Inoue H, Fujiki A, Origasa H, Ogawa S, Okumura K, Kubota I, Aizawa Y, Yamashita T, Atarashi H, Horie M, Ohe T, Doi Y, Shimizu A, Chishaki A, Saikawa T, Yano K, Kitabatake A, Mitamura H, Kodama I, Kamakura S. Inoue H, et al. Among authors: origasa h. Int J Cardiol. 2009 Oct 2;137(2):102-7. doi: 10.1016/j.ijcard.2008.06.029. Epub 2008 Aug 8. Int J Cardiol. 2009. PMID: 18691774
263 results